Efficacy and Safety of Two Doses of Formoterol Fumarate MDI (PT005) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD), Compared to Foradil® Aerolizer® as an Active Control

Stopped Similar data obtained in another study \[see NCT01085045\], therefore study not implemented.

Conditions

• COPD

Interventions

• DRUG: Inhaled PT005
• DRUG: Inhaled Placebo
• DRUG: Formoterol Fumarate 12 µg (Foradil Aerolizer)

Sponsor

Pearl Therapeutics, Inc.